MEDBOX | Toolbox Clinical Guidelines

World Health Organization WHO (2022) C_WHO

3 March 2022 The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges

Tags: remdesivir, therapeutic agents, therapeutic use, COVID-19, ivermectin,

Source: https://apps.who.int/iris/bitstream/hand

Revised case report form for confirmed Novel Coronavirus COVID-19 (‎‎‎report to WHO within 48 hours of case identification)‎‎‎

World Health Organization WHO (2022) C_WHO

22 July 2022

Tags: case report, COVID-19, Surveillance,

Source: https://apps.who.int/iris/rest/bitstream

World Health Organization WHO (2022) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. This updated (fourth) version contains three new recommendations regarding hospitalized patients with severe or critical COVID-1

Tags: clinical care, Treatment, guideline, COVID-19, oxygen, therapy, intubation, hypoxaemic respiratory,

Source: https://apps.who.int/iris/rest/bitstream

Organisation Mondiale de la Santé OMS (2022) C_WHO

Tags: clinical care, Treatment, guideline, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Organisation Mondiale de la Santé OMS (2022) C_WHO

Tags: clinical care, Treatment, guideline, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Consideraciones sobre el uso de antivirales, anticuerpos monoclonales y otras intervenciones para el manejo de pacientes con COVID-19 en América Latina y el Caribe

Organización Mundial de la Salud OMS (2022) C_WHO

26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunación del paciente y los costos asociados con el uso de antivirales, anticuerpos monoclonales y otras intervenciones

Tags: COVID-19, antivirales, therapy, therapeutic, antiretrovirals, Access,

Source: https://iris.paho.org/bitstream/handle/1

Considerations on the Use of Antivirals, Monoclonal Antibodies, and Other Interventions for the Management of COVID-19 Patients in Latin America and the Caribbean

World Health Organization WHO; PAHO; et al. (2022) CC

May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently, the WHO and the PAHO recommend the use of corticosteroids, tocilizumab, baricitinib, and casirivimab e imdevimab (the latter in seronegative COVID-19 patients) and propose the use of sotrovimab, casirivimab/imdevimab, and molnupiravir in patients with non-severe illness who are at high risk for complication

Tags: Treatment, COVID-19, Clinical Guidelines, therapeutic agents,

Source: https://iris.paho.org/bitstream/handle/1

World Health Organization WHO (2022) C_WHO

First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for use in the care of critically ill patients – from hospital entry to hospital discharge. The 2022 updated version includes new tools and adapted algorithms, checklists, memory aids for COVID-19 and influenza, and the latest clinical evidence regarding clinical management of SARI. It is intended to help clinicians care for SARI patients: from epidemiology of severe acute respiratory infections, screening and triage, infection prevention and control, monitoring of patients, laboratory diagnosis, principles of oxygen therapy and different types of ventilation (invasive and non-invasive), as well as antimicrobial and immunomodulator therapies, to ethical and quality of care assessments. The first edition is availbel in Ukrainian and Russia

Tags: clinical care, Training, toolkit, COVID-19, healthcare, Health Workers, Respiratory Infections, Pneumonia, sepsis, septic shock, acute respiratory infections, oxygen, Ventilation,

Source: https://apps.who.int/iris/rest/bitstream

Pan American Health Organisation PAHO (2022) C_WHO

This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically update this review and corresponding recommendations as new evidence becomes available

Tags: COVID-19, SARS-CoV-2, therapeutic, therapy,

Source: https://iris.paho.org/bitstream/handle/1

COVID-19 clinical care pathway (‎CARE)‎: confirm SARS-CoV-2 infection, assess symptoms, risk factors and severity, respond with appropriate care and treatment, evaluate clinical response and recovery

World Health Organization WHO (2022) CC

The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19. The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID-19: living guideline published on the 14 January 2022 and the third version of the WHO COVID-19 Clinical management: living guidance published on the 23 November 2021

Tags: clinical pathway, COVID-19, clinical management, poster,

Source: https://apps.who.int/iris/rest/bitstream

	Therapeutics and COVID-19: living guideline (Arabic) World Health Organization WHO (2022) C_WHO View PDF(19) Download (8) Add to my MEDBOX 3 March 2022 The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges Tags: remdesivir, therapeutic agents, therapeutic use, COVID-19, ivermectin, Source: https://apps.who.int/iris/bitstream/hand
	Revised case report form for confirmed Novel Coronavirus COVID-19 (‎‎‎report to WHO within 48 hours of case identification)‎‎‎ World Health Organization WHO (2022) C_WHO View PDF(1) Download (1) Add to my MEDBOX 22 July 2022 Tags: case report, COVID-19, Surveillance, Source: https://apps.who.int/iris/rest/bitstream
	Clinical management of COVID-19: Living guideline, 23 June 2022 World Health Organization WHO (2022) C_WHO View PDF(69) Download (93) Add to my MEDBOX The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. This updated (fourth) version contains three new recommendations regarding hospitalized patients with severe or critical COVID-1 Tags: clinical care, Treatment, guideline, COVID-19, oxygen, therapy, intubation, hypoxaemic respiratory, Source: https://apps.who.int/iris/rest/bitstream
	Traitements contre la COVID-19 : orientations évolutives, 3 mars 2022 Organisation Mondiale de la Santé OMS (2022) C_WHO View PDF(11) Download (11) Add to my MEDBOX Tags: clinical care, Treatment, guideline, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Opciones terapéuticas y COVID-19: orientaciones evolutivas, 3 de marzo de 2022 Organisation Mondiale de la Santé OMS (2022) C_WHO View PDF(6) Download (4) Add to my MEDBOX Tags: clinical care, Treatment, guideline, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Consideraciones sobre el uso de antivirales, anticuerpos monoclonales y otras intervenciones para el manejo de pacientes con COVID-19 en América Latina y el Caribe Organización Mundial de la Salud OMS (2022) C_WHO View PDF(13) Download (15) Add to my MEDBOX 26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunación del paciente y los costos asociados con el uso de antivirales, anticuerpos monoclonales y otras intervenciones Tags: COVID-19, antivirales, therapy, therapeutic, antiretrovirals, Access, Source: https://iris.paho.org/bitstream/handle/1
	Considerations on the Use of Antivirals, Monoclonal Antibodies, and Other Interventions for the Management of COVID-19 Patients in Latin America and the Caribbean World Health Organization WHO; PAHO; et al. (2022) CC View PDF(6) Download (9) Add to my MEDBOX May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently, the WHO and the PAHO recommend the use of corticosteroids, tocilizumab, baricitinib, and casirivimab e imdevimab (the latter in seronegative COVID-19 patients) and propose the use of sotrovimab, casirivimab/imdevimab, and molnupiravir in patients with non-severe illness who are at high risk for complication Tags: Treatment, COVID-19, Clinical Guidelines, therapeutic agents, Source: https://iris.paho.org/bitstream/handle/1
	Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation World Health Organization WHO (2022) C_WHO View PDF(106) Download (311) Add to my MEDBOX First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for use in the care of critically ill patients – from hospital entry to hospital discharge. The 2022 updated version includes new tools and adapted algorithms, checklists, memory aids for COVID-19 and influenza, and the latest clinical evidence regarding clinical management of SARI. It is intended to help clinicians care for SARI patients: from epidemiology of severe acute respiratory infections, screening and triage, infection prevention and control, monitoring of patients, laboratory diagnosis, principles of oxygen therapy and different types of ventilation (invasive and non-invasive), as well as antimicrobial and immunomodulator therapies, to ethical and quality of care assessments. The first edition is availbel in Ukrainian and Russia Tags: clinical care, Training, toolkit, COVID-19, healthcare, Health Workers, Respiratory Infections, Pneumonia, sepsis, septic shock, acute respiratory infections, oxygen, Ventilation, Source: https://apps.who.int/iris/rest/bitstream
	Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022 Pan American Health Organisation PAHO (2022) C_WHO View PDF(14) Download (18) Add to my MEDBOX This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically update this review and corresponding recommendations as new evidence becomes available Tags: COVID-19, SARS-CoV-2, therapeutic, therapy, Source: https://iris.paho.org/bitstream/handle/1
	COVID-19 clinical care pathway (‎CARE)‎: confirm SARS-CoV-2 infection, assess symptoms, risk factors and severity, respond with appropriate care and treatment, evaluate clinical response and recovery World Health Organization WHO (2022) CC View PDF(17) Download (15) Add to my MEDBOX The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19. The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID-19: living guideline published on the 14 January 2022 and the third version of the WHO COVID-19 Clinical management: living guidance published on the 23 November 2021 Tags: clinical pathway, COVID-19, clinical management, poster, Source: https://apps.who.int/iris/rest/bitstream

About MEDBOX

MEDBOX Video Series